Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

NYSE:CLVT - New York Stock Exchange, Inc. - JE00BJJN4441 - Common Stock - Currency: USD

4.29  -0.02 (-0.46%)

After market: 4.32 +0.03 (+0.7%)

Fundamental Rating

3

CLVT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. There are concerns on the financial health of CLVT while its profitability can be described as average. CLVT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CLVT had positive earnings in the past year.
CLVT had a positive operating cash flow in the past year.
CLVT had negative earnings in each of the past 5 years.
Each year in the past 5 years CLVT had a positive operating cash flow.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

Looking at the Return On Assets, with a value of -5.81%, CLVT is doing worse than 75.61% of the companies in the same industry.
CLVT has a worse Return On Equity (-13.00%) than 76.83% of its industry peers.
CLVT's Return On Invested Capital of 1.84% is on the low side compared to the rest of the industry. CLVT is outperformed by 63.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLVT is significantly below the industry average of 13.48%.
The last Return On Invested Capital (1.84%) for CLVT is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -5.81%
ROE -13%
ROIC 1.84%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.83%
ROIC(5y)1.31%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

CLVT's Operating Margin of 9.16% is fine compared to the rest of the industry. CLVT outperforms 71.95% of its industry peers.
In the last couple of years the Operating Margin of CLVT has grown nicely.
Looking at the Gross Margin, with a value of 66.00%, CLVT is in the better half of the industry, outperforming 78.05% of the companies in the same industry.
In the last couple of years the Gross Margin of CLVT has remained more or less at the same level.
Industry RankSector Rank
OM 9.16%
PM (TTM) N/A
GM 66%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLVT is destroying value.
Compared to 1 year ago, CLVT has more shares outstanding
CLVT has more shares outstanding than it did 5 years ago.
CLVT has a worse debt/assets ratio than last year.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CLVT has an Altman-Z score of -0.34. This is a bad value and indicates that CLVT is not financially healthy and even has some risk of bankruptcy.
CLVT's Altman-Z score of -0.34 is on the low side compared to the rest of the industry. CLVT is outperformed by 79.27% of its industry peers.
CLVT has a debt to FCF ratio of 13.88. This is a negative value and a sign of low solvency as CLVT would need 13.88 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.88, CLVT is in line with its industry, outperforming 42.68% of the companies in the same industry.
CLVT has a Debt/Equity ratio of 0.88. This is a neutral value indicating CLVT is somewhat dependend on debt financing.
CLVT has a Debt to Equity ratio of 0.88. This is in the lower half of the industry: CLVT underperforms 69.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 13.88
Altman-Z -0.34
ROIC/WACC0.26
WACC7.17%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CLVT has a Current Ratio of 0.87. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.87, CLVT is not doing good in the industry: 79.27% of the companies in the same industry are doing better.
CLVT has a Quick Ratio of 0.87. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLVT's Quick ratio of 0.87 is on the low side compared to the rest of the industry. CLVT is outperformed by 79.27% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CLVT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.33%.
CLVT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.87% yearly.
The Revenue has decreased by -2.74% in the past year.
The Revenue has been growing by 21.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-6.33%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-2.74%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.43%

3.2 Future

The Earnings Per Share is expected to grow by 3.22% on average over the next years.
CLVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.89% yearly.
EPS Next Y-11.75%
EPS Next 2Y-2.12%
EPS Next 3Y2.19%
EPS Next 5Y3.22%
Revenue Next Year-8.14%
Revenue Next 2Y-3.94%
Revenue Next 3Y-1.59%
Revenue Next 5Y1.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

CLVT is valuated cheaply with a Price/Earnings ratio of 5.80.
Compared to the rest of the industry, the Price/Earnings ratio of CLVT indicates a rather cheap valuation: CLVT is cheaper than 91.46% of the companies listed in the same industry.
CLVT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.85.
With a Price/Forward Earnings ratio of 6.05, the valuation of CLVT can be described as very cheap.
Based on the Price/Forward Earnings ratio, CLVT is valued cheaply inside the industry as 96.34% of the companies are valued more expensively.
CLVT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.77.
Industry RankSector Rank
PE 5.8
Fwd PE 6.05
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLVT indicates a rather cheap valuation: CLVT is cheaper than 82.93% of the companies listed in the same industry.
CLVT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLVT is cheaper than 92.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9
EV/EBITDA 7.43
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.12%
EPS Next 3Y2.19%

0

5. Dividend

5.1 Amount

No dividends for CLVT!.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (5/1/2025, 8:53:00 PM)

After market: 4.32 +0.03 (+0.7%)

4.29

-0.02 (-0.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners62.29%
Inst Owner ChangeN/A
Ins Owners0.91%
Ins Owner Change13.28%
Market Cap2.93B
Analysts77.33
Price Target5.67 (32.17%)
Short Float %12.3%
Short Ratio6.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP-5.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.91%
Min EPS beat(2)0.21%
Max EPS beat(2)1.61%
EPS beat(4)3
Avg EPS beat(4)2.13%
Min EPS beat(4)-1.33%
Max EPS beat(4)8.03%
EPS beat(8)7
Avg EPS beat(8)6.04%
EPS beat(12)11
Avg EPS beat(12)8.78%
EPS beat(16)14
Avg EPS beat(16)7.23%
Revenue beat(2)0
Avg Revenue beat(2)-3.17%
Min Revenue beat(2)-4.81%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.37%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)-0.95%
Revenue beat(8)1
Avg Revenue beat(8)-1.75%
Revenue beat(12)2
Avg Revenue beat(12)-1.74%
Revenue beat(16)3
Avg Revenue beat(16)-1.62%
PT rev (1m)-6.32%
PT rev (3m)-12.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.31%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)-11.49%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)-7.63%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-8.1%
Valuation
Industry RankSector Rank
PE 5.8
Fwd PE 6.05
P/S 1.15
P/FCF 9
P/OCF 4.53
P/B 0.57
P/tB N/A
EV/EBITDA 7.43
EPS(TTM)0.74
EY17.25%
EPS(NY)0.71
Fwd EY16.52%
FCF(TTM)0.48
FCFY11.11%
OCF(TTM)0.95
OCFY22.06%
SpS3.74
BVpS7.52
TBVpS-7.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.81%
ROE -13%
ROCE 2.33%
ROIC 1.84%
ROICexc 1.9%
ROICexgc N/A
OM 9.16%
PM (TTM) N/A
GM 66%
FCFM 12.73%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.83%
ROIC(5y)1.31%
ROICexc(3y)1.89%
ROICexc(5y)1.35%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.31%
ROCE(5y)1.66%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 13.88
Debt/EBITDA 4.7
Cap/Depr 44.17%
Cap/Sales 12.56%
Interest Coverage 0.88
Cash Conversion 67.27%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z -0.34
F-Score6
WACC7.17%
ROIC/WACC0.26
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.33%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-11.75%
EPS Next 2Y-2.12%
EPS Next 3Y2.19%
EPS Next 5Y3.22%
Revenue 1Y (TTM)-2.74%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.43%
Revenue Next Year-8.14%
Revenue Next 2Y-3.94%
Revenue Next 3Y-1.59%
Revenue Next 5Y1.89%
EBIT growth 1Y-12.12%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9366.24%
EBIT Next 3Y361.89%
EBIT Next 5Y157.15%
FCF growth 1Y-34.41%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-13.11%
OCF growth 3Y25.93%
OCF growth 5Y40.62%